Clinical Trials Directory

Trials / Unknown

UnknownNCT04667598

Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Jun Li · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To elucidate the efficacy and safety of weixin decoction in the treatment of heart failure after myocardial infarction.

Detailed description

To elucidate the long-term protective effect of flavored Wenxin Decoction on heart failure after myocardial infarction. To elucidate the effective components in the treatment of heart failure and the mechanism of metabolism regulation.

Conditions

Interventions

TypeNameDescription
DRUGModified Wenxin DecoctionMainly including make aconite , astragalus , Cassia twig , dried ginger , red peony root , Chuanxiong , Codonopsis codonopsis , Ophiopogon ophiopogon , Schisandra , Stamen , Asarum , licorice.

Timeline

Start date
2020-12-15
Primary completion
2022-06-30
Completion
2023-06-30
First posted
2020-12-14
Last updated
2020-12-14

Source: ClinicalTrials.gov record NCT04667598. Inclusion in this directory is not an endorsement.